Therapeutic horizons for amyotrophic lateral sclerosis
Open Access
- 31 October 1996
- journal article
- review article
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 6 (5) , 679-687
- https://doi.org/10.1016/s0959-4388(96)80103-6
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Excitotoxicity hypothesisNeurology, 1996
- Superoxide dismutase and familial amyotrophic lateral sclerosis: New insights into mechanisms and treatmentsAnnals of Neurology, 1996
- Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic miceCell, 1995
- [3H]d-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic studyBrain Research, 1994
- Evidence for autoimmunity in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1994
- Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line.Proceedings of the National Academy of Sciences, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1992
- Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1992
- Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction.Proceedings of the National Academy of Sciences, 1991